Genomic Diagnostics Company Veracyte Strengthens Medical Team
Aitechpark06 Jul, 2021Technology
Veracyte (Nasdaq: VCYT), a global genomic diagnostics company, today announced key appointments that expand and further strengthen the company?s medical team. William A. Bulman, M.D. and Paul Kelly Marcom, M.D, have joined the company as medical director for Lung Cancer and medical director for Breast Cancer, respectively. Both physician executives report to Richard T. Kloos, M.D., Veracyte?s executive medical director.
Related Bookmarks
- McAfee Receives Success Memorandum From DIU for MVISION UCE
- Looking For Hot Line Reel?
- Affordable Solar Installation Services in Tucson
- Get Apple iPad Air Battery Replacement | Tech Doc
- The global hemoglobin A1C testing devices market -Existing and Future Insights
- Oilfield Drill Bits Market Research Report (2021-2026)
- Product Update: Add Skill, Filter Skill Based Resources, Move Tasks along with Assignee & More
- 6 Major Benefits Of Displaying Facebook Reviews On Websites
- The usage of Natural Language Processing (NLP) in Healthcare and Life Sciences has increased over th
- SQL Server Data Quality Services
Recent Profiles
Unique Travel Morocco
X881nett
Nhacaitx88forum
Rushi
Model Landscape
Pgslot
55ganhe
Microbee
Umzugsfirma Zürich
Ada